Patients on semaglutide ( Ozempic, Wegovy) had a 32% increased relative risk of developing nonarteritic anterior ischemic ...

The Medicines and Healthcare products Regulatory Agency issued an alert as a crackdown on prescriptions was underway ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has confirmed the toll up to the end of January with 82 people ...

The FDA said weight-loss and diabetes drugs Wegovy and Ozempic are no longer on shortage list. The U.S. Food and Drug ...

Ozempic, Mounjaro and Wegovy may not be the lightbulb, jet airplane or internet, but their impact is expected to be so ...

The FDA has announced that the shortage of Wegovy and Ozempic, medications used for weight loss and diabetes management, is ...

Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply, the FDA declared ...

In December, the FDA declared that shortages of treatments Zepbound and Mounjaro from another drugmaker, Eli Lilly and Co., ...

Feb. 21, the Food and Drug Administration said there is no longer a short supply of the weight loss and diabetes drugs Wegovy ...

Nicole started Wegovy when she was unable to obtain Ozempic amid the shortage of the drug, which is used for diabetes. But the 51-year-old has also experienced a plateau in weight loss.

Wegovy is the first GLP-1 medication for weight loss to gain approval from the Food and Drug Administration (FDA). The organization approved it in 2021. However, there are strict eligibility ...